The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DUETTE: A randomized phase II study to assess a second maintenance treatment with olaparib (ola) or ola+ceralasertib (cer), in patients (pts) with platinum-sensitive relapsed (PSR) epithelial ovarian cancer who have previously received PARP inhibitor maintenance treatment (NCT04239014).
 
Amit M. Oza
Honoraria - Intas
Consulting or Advisory Role - Immunogen; Merck KGaA
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro
 
Andrew Pierce
Employment - AstraZeneca/MedImmune
 
Alan Lau
Employment - AstraZeneca
 
Nisha Kurian
Employment - AstraZeneca
 
Graeme Parr
Employment - AstraZeneca
 
Si-Houy Lao-Sirieix
Employment - AstraZeneca
 
Mei Lin W. Ah-See
Employment - AstraZeneca
 
Emma Dean
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca/MedImmune
Travel, Accommodations, Expenses - AstraZeneca
 
Bienvenu Loembé
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Honoraria - AstraZeneca